• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Extended letrozole therapy improves disease-free survival in postmenopausal patients with breast cancer

byTeddy Guo
October 6, 2021
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click to read the study in The Lancet Oncology.

RELATED REPORTS

Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen 

GLP-1 receptor agonists show little effect on obesity-related cancer risk

Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines

Tags: Breast Cancerbreast cancer survivalearly breast cancerhormone receptor-positive breast cancerletrozoleLetrozole (Femara)postmenopausaltamoxifen
Previous Post

#VisualAbstract: Quadruple combination pill for hypertension is more effective at lowering blood pressure than standard dose monotherapy

Next Post

Prophylactic scopolamine butylbromide reduces death rattle at end of life compared to placebo

RelatedReports

2 Minute Medicine Rewind March 4, 2019
Chronic Disease

Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen 

December 10, 2025
Many new pediatric asthma cases attributable to obesity
Chronic Disease

GLP-1 receptor agonists show little effect on obesity-related cancer risk

December 8, 2025
Lisinopril and carvedilol reduce cardiotoxicity in breast cancer patients receiving trastuzumab and anthracyclines
Cardiology

Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines

December 8, 2025
Patient Basics: Hot Flashes
Health

Self-Administered Hypnosis vs Sham Hypnosis for Hot Flashes: A Randomized Clinical Trial

November 18, 2025
Next Post
Pediatric chronic pain patients typically Caucasian, female adolescents.

Prophylactic scopolamine butylbromide reduces death rattle at end of life compared to placebo

Influenza vaccine not associated with increased risk of epilepsy in children

Vaccine-induced immune thrombotic thrombocytopenia may worsen the severity of cerebral venous thrombosis

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Methylprednisolone in severe COVID-19 pneumonia associated with clinical benefit in those with high baseline serum ferritin

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry
  • Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
  • Weekly islatravir plus lenacapavir maintains HIV virologic suppression
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.